Bagster Bag Market is Estimated To Witness High Growth Owing To Increased Demise of Landfills10/30/2023 The Bagster Bag Market is estimated to be valued at US$ 490.4 million in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Bagster bags are heavy-duty garbage bags that allow homeowners to dispose of large amounts of unwanted items from home renovation projects, spring cleaning, and yard maintenance. The bags range in size from 3 to 30 cubic yards and are designed for both indoor and outdoor use. Bagster bags provide a convenient solution for bulky waste disposal as they eliminate the need for multiple trips to the landfill. Market key trends: Demand for alternative waste disposal solutions is growing due to the increasing demise of landfills across major economies. According to the Environmental Protection Agency, the number of landfills in the United States declined from 8,000 in the 1980s to around 2,000 presently due to land and environmental constraints. This has prompted waste management companies to offer convenient on-call pickup services for bulky household waste using Bagster bags. The bags allow compacting more trash into less space, thereby assisting waste haulers in improving operational efficiency. Their reuse-friendly design also supports the transition toward a circular economy. Porter’s Analysis Threat of new entrants: The bagster bag market is moderately concentrated with few established players dominating the market making it difficult for new entrants due increasing investments required. Bargaining power of buyers: The bargaining power of buyers is moderate as there are substitute products available at cheaper prices. However, bagster bags offer convenience in safely disposing household waste. Bargaining power of suppliers: The availability of raw materials gives suppliers moderate bargaining power. However, established suppliers dealing with major players have less bargaining power. Threat of new substitutes: Alternatives like self-haul to transfer stations pose threat. However, bagster bags offer ease and safety of waste disposal at doorstep driving its demand. Competitive rivalry: High due to presence of major players and aggressive marketing strategies adopted by them to increase market share. SWOT Analysis Strength: Bagster bags offer convenience and safety in disposing household waste. Wide distribution network of major players. Weakness: High costs involved makes it unaffordable for some customers. Dependency on raw material prices expose to supply chain disruptions. Opportunity: Growing urbanization and awareness about proper waste disposal drives market growth. Entering developing markets presents vast opportunities. Threats: Strict regulations regarding waste disposal increases compliance costs. Substitute products available at lower prices pose threat. Key Takeaways The global Bagster Bag Market Share is expected to witness high growth at a CAGR of 6.6% over the forecast period, due to increasing generation of household waste. Urbanization and changing lifestyles have increased waste production driving demand for bagster bags to safely dispose them. The US dominates the bagster bag market owing to large number of households and strict rules regarding management of household hazardous waste, accounting for over 30% of global market share. Europe is the second largest market led by Germany, UK and France. Asia Pacific is expected to grow at fastest pace during the forecast period led by China, India and other developing nations where waste generation is increasing at faster pace along with rising income levels. Key players operating in the bagster bag market are Waste Management Inc., Republic Services Inc., Clean Harbors Inc., Covanta Holding Corporation, Stericycle Inc., Advanced Disposal Services, Casella Waste Systems, Recology, Biffa, REMONDIS SE & Co. KG. Major players focus on new product launches catering to various applications to strengthen their market position. Read More, https://www.newsstatix.com/bagster-bag-market-trends-size-and-share-analysis/
0 Comments
The Bacteriophage Therapy Market is estimated to be valued at US$ 1,280.9 million in 2023 and is expected to exhibit a CAGR of 3.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Bacteriophage therapy involves the use of bacteriophages or bacterial viruses to treat pathogenic bacterial infections. It utilizes bacteriophages that are specific to infect and lyse bacterial pathogens while leaving other members of the microbiota unharmed. Market Dynamics: The growth of the bacteriophage therapy market is driven by factors such as rising cases of antimicrobial resistance, growing need for alternative treatment options, and favorable research funding from regulatory agencies. Antimicrobial resistance has emerged as a major public health threat with WHO projecting that antimicrobial-resistant pathogens could cause 10 million deaths each year by 2050 if no action is taken. This has escalated the need to explore new treatment modalities like bacteriophage therapy. Market key trends: One of the key trends in the bacteriophage therapy market is the rise in antibiotic resistance. There is an increasing number of bacteria that have become resistant to antibiotics which were previously effective in treating bacterial infections. This has created an urgent need to develop alternative treatment options. Bacteriophages offer potential to target antibiotic-resistant bacterial strains and confer therapeutic benefits. Another key trend is the focus on development of phage cocktails or broad-range phages that can treat multiple bacterial infections. Phage banks and therapeutic phage libraries are being established to enable effective treatment of multi-drug resistant infections. SWOT Analysis Strengths: High specificity for target bacteria without harming human cells; Natural selection process helps adapt to antibiotic resistance. Weaknesses: Regulatory hurdles for their clinical use; Limited host range of individual phages. Opportunities: Potential to treat antibiotic-resistant bacterial infections; Growing R&D for therapeutic applications of phages. Threats: Time consuming and costly development; Phage resistance in bacteria. Key Takeaways The global Bacteriophage Therapy Market Share size is expected to witness high growth, exhibiting CAGR of 3.7% over the forecast period of 2023-2030, due to rising antibiotic resistance. The market was valued at US$ 1,280.9 million in 2023. Regional analysis: The US region currently dominates the market owing to ongoing clinical research on bacteriophage therapy. Europe is also emerging as a major market supported by several companies conducting clinical trials of phage therapeutics in countries like UK and France. Key players: Key players operating in the bacteriophage therapy market are Armata Pharmaceuticals, Inc., Eliava Biopreparations Ltd., Pherecydes Pharma, Intralytix, Inc., Phagelux, Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Adaptive Phage Therapeutics, Enbiotix, Inc., Intodeworld, Inc., BiomX Ltd., Phi Therapeutics, Fixed-phage Ltd., Micreos BV, ContraFect Corporation, OPTIPHARM Co., Ltd. Read More, https://www.insightprobing.com/bacteriophage-therapy-market-trends-size-and-share-analysis/ Neurofeedback Market is Estimated To Witness High Growth Owing To Mobile Neurofeedback Applications10/30/2023 The Anti Radiation Drugs Market is estimated to be valued at US$ 587.4 million in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Anti radiation drugs are pharmaceutical drugs used in the treatment or prevention of damage caused by ionizing radiation such as that produced during radiation therapy for cancer treatment. These drugs help protect healthy tissues and cells from radiation damage during cancer treatment or after nuclear accidents. They work by limiting damage to healthy cells and supporting DNA repair mechanisms. With rising cancer cases globally, the need for radiation therapy and associated anti radiation drugs is increasing. Market key trends: The anti radiation drugs market is expected to witness high growth owing to increasing investment in R&D of innovative pipeline drugs. Companies are focusing on developing novel drug formulations that offer higher radioprotection with less side effects. For instance, in 2020, RxBio Inc., a clinical-stage biopharmaceutical company received US$ 30M funding to develop its lead compound RxB-100 for protection against acute radiation syndrome. The funding will aid in advancing its Phase 2 trial and developing the drug for sales in strategic markets. Such funded pipeline products are expected to gain regulatory approvals and commercialization in the forecast period, driving the market growth. Porter’s Analysis Threat of new entrants: Low capital requirements to enter the market pose low threat of new entrants. However, presence of stringent regulations and need for extensive R&D pose barriers. Bargaining power of buyers: Large pharmaceutical companies have significant bargaining power over smaller players due to their large market dominance and purchasing power. Bargaining power of suppliers: Few globally operating suppliers for active pharmaceutical ingredients give them strong bargaining power over drug makers. Threat of new substitutes: Threat from substitutes is low due to lack of replacements for radiation therapies for cancer treatment. Competitive rivalry: Market comprised of few players intensifies competition for market share and pricing pressures. SWOT Analysis Strength: Strong product pipeline focusing on developing innovative therapies using immunotherapy. Rising healthcare expenditure supports market growth. Weakness: High costs associated with R&D, clinical trials and regulatory approvals. Higher risks of failure for new drug candidates during clinical trials. Opportunity: Emerging economies with large patient pool provide scope for market expansion. Collaborations allow companies to gain access to newer technologies. Threats: Stringent regulations have led to delays in approvals. Side effects and risks associated with radiotherapy raises safety concerns. Key Takeaways The global Anti Radiation Drugs Market Share is expected to witness high growth, exhibiting CAGR of 6.8% over the forecast period, due to increasing incidence of cancer cases globally. Rising use of radiation therapies for cancer treatment is augmenting demand for protective anti-radiation drugs. The US market held largest share in 2023 owing to well established healthcare infrastructure, presence of advanced research facilities and rising healthcare spending. Emerging markets of China and India are expected to be fastest growing regions due to large patient population, growing per capita healthcare expenditure and increasing penetration of health insurance. Key players operating in the Anti Radiation Drugs market are RxBio Inc., Annova Chem Inc., Medicom Healthcare Ltd., Onconova Therapeutics, Genome Protection Inc., Grace Therapeutics LLC, Amgen Inc., Partner Therapeutics Inc., Jubilant Life Sciences Ltd., Cipla Inc., Stium Inc., Soligenix Inc., Aeolus Pharmaceuticals, PharmaIN Corp, Immune Modulators Inc. Major players are focusing on product launches, partnerships and acquisitions to strengthen distribution networks and pipelines. Read More, https://www.newsstatix.com/anti-radiation-drugs-market-trends-size-and-share-analysis/ The global neurofeedback market is estimated to be valued at US$ 1,253.5 million in 2022 and is expected to exhibit a CAGR of 7.33% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: The neurofeedback market involves techniques that use real-time displays of brain activity, most commonly electroencephalography (EEG) biofeedback, to teach self-regulation of brain function.Neurofeedback enables monitoring of brain waves in real-time and provides visual, auditory or tactile feedback to reinforce EEG patterns associated with calm, focused and engaged mental states. This helps in training individuals to voluntary control their own brain function. Market key trends: One of the major trend in neurofeedback market is rising adoption of alpha-theta neurofeedback training. Alpha-theta neurofeedback training uses real-time monitoring of brainwaves to trigger alpha (7.5-12 Hz) and theta (4-7 Hz) brainwave activity associated with deep relaxation and access to unconscious memories through guided imagery. This technique is gaining increasing acceptance in treatment of depression, anxiety, PTSD, addiction and attention problems as it helps improve mood, reduce stress and enhance self-awareness by accessing unconscious parts of the brain. Segment Analysis The global neurofeedback market is segmented by hardware into EEG, EEG sensors, and other devices. Among them, the EEG sensors segment dominates the market owing to increasing usage of EEG sensors for neurofeedback therapy. EEG sensors help in recording neural oscillations or brain wave activity by detecting voltage fluctuations resulting from ionic current flows within the neurons of the brain. They require wearing sensors on the scalp that detect the electromagnetic fields produced by brain activity. This helps in collecting real-time data about a patient's brainwaves which is fed back to them to help achieve control over their brain activity. Key Takeaways The global Neurofeedback Market Share is expected to witness high growth, exhibiting CAGR of 7.33% over the forecast period 2022-2030, due to increasing adoption of neurofeedback therapy for treating neurological disorders such as ADHD, insomnia, anxiety, depression and epilepsy. The global neurofeedback market size is estimated to reach US$ 1,253.5 million by 2023. Regional analysis North America dominates the neurofeedback market owing to rising awareness regarding neurofeedback therapy in the region. The U.S. holds the highest share in the North American as well as global neurofeedback market due to growing usage of neurofeedback for the treatment of ADHD and seizures. Europe is the second largest regional market due to increasing adoption of neurotherapy for treating mental health disorders in the region. Key players Neuro Care Group, Brainmaster Technologies, Inc., and Thought Technology Ltd. are the leading players operating in the neurofeedback market. Key players are focusing on new product launches and strategic collaborations to strengthen their position in the market. For instance, in March 2021, Neuro Care Group launched an app-based neurofeedback device called Enclothed which can be used at home. Read More, Https://Www.Insightprobing.Com/Neurofeedback-Market-Trends-Size-And-Share-Analysis/ The global data governance market is estimated to be valued at US$2.06 Bn in 2021 and is expected to exhibit a CAGR of 21.2% over the forecast period of 2022-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Data governance refers to the overall management of the availability, usability, integrity, and security of data within an organization. It involves the establishment of policies, procedures, and controls to ensure the proper handling of data. With the increasing volume and complexity of data generated by organizations, the need for effective data governance solutions has become paramount. Data governance solutions help organizations in managing data quality, ensuring compliance with regulations, mitigating risks, and improving decision-making processes. The growing adoption of data governance solutions across various industries is expected to drive the market growth. Market Key Trends: One key trend in the data governance market is the growing adoption of cloud-based data governance solutions. Cloud-based data governance solutions offer several advantages such as scalability, flexibility, cost-effectiveness, and ease of deployment. These solutions enable organizations to centrally manage and govern their data across multiple cloud platforms and on-premises environments. The increasing need for remote access to data and the rising popularity of hybrid cloud environments are fueling the demand for cloud-based data governance solutions. Moreover, advancements in cloud technologies, such as artificial intelligence and machine learning, are further enhancing the capabilities of these solutions, driving their adoption in the market. Segment Analysis: The data governance market can be segmented based on component, organization size, deployment mode, and vertical. Based on the component, the market can be classified into solutions and services. Solutions segment is dominating the market as there is a growing demand for data governance solutions to manage and govern data effectively. The solutions segment is further categorized into data discovery and categorization, data quality management, data catalog and metadata management, data lineage and life cycle management, and others. Among these, data quality management is the dominating sub-segment. Organizations are increasingly focusing on maintaining data quality to ensure accurate and reliable insights and decisions. Data quality management solutions help in identifying and resolving data issues, improving data consistency, and enhancing overall data integrity. Key Takeaways: The global Data Governance Market Share is expected to witness high growth, exhibiting a CAGR of 21.2% over the forecast period of 2022-2030. This growth can be attributed to increasing digitalization trends across various industries, resulting in a massive volume of data generation. Moreover, stringent regulations and compliance requirements, such as the General Data Protection Regulation (GDPR), have necessitated the implementation of robust data governance solutions. Companies are increasingly realizing the importance of data governance in maintaining data integrity, improving data quality, and ensuring regulatory compliance. In terms of regional analysis, North America is the fastest-growing and dominating region in the data governance market. The region has a strong presence of major players and a high adoption rate of advanced technologies. The presence of strict data protection regulations and the increasing investments in data governance solutions are driving the market growth in this region. Furthermore, the Asia Pacific region is expected to witness significant growth due to the increasing digital transformation initiatives and the rising demand for data management solutions in countries like China, India, and Japan. Key players operating in the data governance market include Collibra NV, SAP SE, SAS Institute Inc., Symantec Corporation (Norton Lifelock), TIBCO Software Inc., Informatica Inc., Alation Inc., IBM Corporation, Varonis Systems Inc., Alfresco Software Inc., Oracle Corporation, Talend SA, and Microsoft Corporation. These key players are focusing on strategic partnerships, acquisitions, and product innovations to strengthen their market presence and gain a competitive edge. They are also investing in research and development activities to introduce advanced data governance solutions to cater to the evolving needs of organizations. Read More, https://www.insightprobing.com/data-governance-market-trends-size-and-share-analysis/ The global Supply Chain Risk Management Market is estimated to be valued at US$2.9 billion in 2022 and is expected to exhibit a CAGR of 9.2% over the forecast period 2022 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Supply chain risk management involves identifying potential sources of disruption within the supply chain and taking precautionary steps to mitigate risks and ensure business continuity. It helps companies address supply chain disruptions, source better materials/components, and protect brand reputation through diligent monitoring. Market key trends: The market is witnessing growth in adoption of automated and cloud-based supply chain risk management software as it provides real-time monitoring of the supply chain network. It helps track performance, identifies bottlenecks, monitors suppliers and enables scenario modeling to minimize disruptions. Growing complexity of global supply chains and increasing instances of disruptions are encouraging companies to adopt predictive risk analytics solutions to strengthen resilience against uncertainties. Adoption of artificial intelligence and blockchain technology in supply chain risk management is also gaining traction to enable transparency and agility in supply networks. Segment Analysis The global supply chain risk management market is segmented by component, deployment type, organization size, vertical, and geography. By component, the market is divided into software and services. Among these, the software segment dominated in 2021 with a market share of over 60%, as software solutions help identify, assess, and minimize risks in supply chains. By deployment type, the market is bifurcated into on-premises and cloud. The cloud segment is expected to witness higher growth during the forecast period due to the flexibility, scalability, and low upfront costs offered by cloud-based supply chain risk management solutions. Key Takeaways The global Supply Chain Risk Management Market Share size was valued at $2.9 billion in 2021. It is expected to reach $7.3 billion by 2031, exhibiting a CAGR of 9.2% during the forecast period. The increasing complexities and globalization of supply chains have amplified the need to effectively mitigate risks, which is driving the demand for supply chain risk management solutions. Regionally, North America dominated the market with over 35% share in 2021 due to stringent government regulations regarding supply chain transparency. However, Asia Pacific is anticipated to witness the fastest growth over the next few years led by countries like China, India, and Japan. Key players operating in the supply chain risk management market are Avetta, LLC, Cura Software Solutions, DHL International GmbH, GEP, LogicManager, Inc., Marsh LLC, MetricStream Inc., SZ DJI Technology Co. Ltd., SAP Ariba Inc., Software AG, and The AnyLogic Company, and others. Major players are focusing on product launches and enhancements to consolidate their market position. For instance, in 2021, Avetta launched Avetta Connect to help suppliers digitize risk assessments. Read More, https://www.insightprobing.com/supply-chain-risk-management-market-trends-size-and-share-analysis-2/ The global Irish whiskey Market is estimated to be valued at US$ 4.7 Bn or Mn in 2022 and is expected to exhibit a CAGR of 7.44% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Irish whiskey is a premium product category within the spirits market, which is primarily made from malted barley. Irish whiskey is known for its rich taste and smoothness. It is enjoyed as an after-dinner drink worldwide due to its mild flavor. Market key trends: One of the major trends witnessed in the market is the increasing demand for craft Irish whiskey. Unlike standard Irish whiskeys that are produced in large quantities, craft whiskeys are specialty products made in small batches with unique flavors. Craft whiskey makers are experimenting with barrel finishes, custom blending, and unique ingredients to offer differentiated taste profiles to consumers. The premiumization trend and rising popularity of craft spirits are fueling the demand for craft Irish whiskeys globally. Craft producers are leveraging social media platforms to market unique whiskeys and establish a niche customer base. Segment Analysis The Irish whiskey market is segmented by product into Blended Irish whiskey and Single Malt Irish whiskey. The blended Irish whiskey segment dominates the market and accounts for over three-fourths of the total market share due to its smooth texture and easy blending taste profile which appeals to a wide range of consumers. The single malt Irish whiskey segment is expected to witness high growth owing to rising premiumization trends and an increasing number of connoisseurs looking for rare and unique tasting whiskey experiences. Key Takeaways The global Irish Whiskey Market Share is expected to witness high growth, exhibiting a CAGR of 7.44% over the forecast period, due to increasing premiumization trend and growing culture of socializing over aged whiskey. The North American region currently dominates the market with the largest share of over 35% due to increasing consumption in countries like the United States. The Asia Pacific region is expected to exhibit the highest growth during the forecast period driven by emerging middle-class populations and growing acceptance of whiskey as a luxury spirit in countries like China and India. Key players operating in the Irish whiskey market are Beam Suntory, Brown-Forman, Diageo, Pernod Ricard, William Grant & Sons, and Castle Brands. Beam Suntory leads the market with top-selling brands such as Jameson Irish whiskey. Diageo is the second largest player with brands such as Bushmills and several smaller craft brands. The global Irish whiskey market size was valued at US$ 4.7 Billion in 2022 and is expected to reach US$ 8.17 Billion by 2030 expanding at a CAGR of 7.44% during the forecast period. Read More, https://www.insightprobing.com/irish-whiskey-market-trends-size-and-share-analysis/ Report Overview:
The global CRISPR genomic cure Market is estimated to be valued at US$ 1.84 billion in 2022 and is expected to exhibit a CAGR of 34.7% over the forecast period 2023-2030. Market Overview: CRISPR genomic cures utilize the powerful tool of CRISPR gene editing to permanently alter DNA sequences to provide cures for genetic diseases. CRISPR enables precisely editing and modifying genes in living organisms and could potentially provide cures for thousands of genetic diseases. CRISPR offers advantages over conventional treatment options for genetic diseases as it directly targets the root cause of disease by correcting defective genes. Market key trends: One of the key trends in the CRISPR genomic cure market is the increasing adoption of CRISPR gene editing approaches in clinical trials for genetic diseases. Multiple clinical trials are underway to evaluate the safety and efficacy of CRISPR approaches for treating genetic conditions such as sickle cell disease, beta-thalassemia, Duchenne muscular dystrophy, and others. For instance, CRISPR Therapeutics and its partner Vertex Pharmaceuticals are evaluating the use of ex-vivo CRISPR genome editing approach known as CTX001 to treat transfusion-dependent beta-thalassemia and sickle cell disease in separate ongoing clinical trials. Segment Analysis The global CRISPR genomic cure market is segmented based on applications, end use, product and services. By application, the therapeutics segment dominated the market and accounted for the largest revenue share in 2023 owing to the increasing R&D in developing CRISPR-based therapeutics for treating hereditary diseases. By end use, the biopharmaceutical companies segment held the largest market share due to the significant investments made by them in developing novel CRISPR therapies. Key Takeaways The global CRISPR Genomic Cure Market is expected to witness high growth, exhibiting CAGR of 34.7% over the forecast period, due to increasing prevalence of cancer and genetic disorders. North America dominated the market in 2023 and accounted for around 40% of the global market share owing to presence of key market players and availability of advanced healthcare facilities in the region. The global CRISPR genomic cure market size is expected to reach US$ 1.84 billion in 2023. Key players operating in the CRISPR genomic cure market are CRISPR Therapeutics AG, Editas Medicine, Inc., Intellia Therapeutics, Inc., Sangamo Therapeutics, Inc., Beam Therapeutics Inc., Caribou Biosciences, Inc., Mammoth Biosciences, Precision Biosciences, Inc., Synthego Corporation, GenScript Biotech Corporation, Horizon Discovery Group plc, Lonza Group Ltd., Takara Bio Inc., Merck KGaA, Thermo Fisher Scientific Inc. Read More, https://www.insightprobing.com/crispr-genomic-cure-market-trends-size-and-share-analysis Medical Devices Contributing Large Share to The global Brain Computer Interface Market Growth10/27/2023 The global Brain Computer Interface Market is estimated to be valued at US$ 860.4 million in 2022 and is expected to exhibit a CAGR of 11.4% over the forecast period 2021-2028, according to a new report published by Coherent Market Insights.
Market Overview: Brain computer interfaces translate brain signals into actions. They have potential applications in gaming, virtual reality, education and rehabilitation. One of the key advantages of BCIs is that they provide a new communication pathway for people with disabilities. Market key trends: One of the key trends in the BCI market is the rise of non-invasive BCIs. Previously, BCIs required implantable devices but technological advances have led to the development of scalp EEG-based BCIs that do not require surgery. EEG-based BCIs can detect thought patterns related to imagination of movement or object and translate them into actions on a computer screen. This makes BCIs safer and more accessible for consumers. Segment Analysis The global brain computer interface market is segmented into invasive bci and non-invasive bci. The invasive bci segment currently dominates the market, accounting for over 60% market share in 2021. Invasive bci provides higher accuracy brain signals as sensors are implanted directly into the brain. However, the procedure requires surgery which limits its acceptance. The non-invasive bci segment is expected to witness faster growth during the forecast period due to its convenience and safety. Headsets and sleep masks used in non-invasive bci avoid surgery and are easy to use. This will drive its adoption in healthcare and gaming applications going forward. Key Takeaways The global Brain Computer Interface Market Share is expected to witness high growth, exhibiting a CAGR of 11.4% over the forecast period from 2021 to 2028, due to increasing demand for assistive technologies for disabled people and growth in consumer applications of BCIs like gaming. Regional analysis - North America currently dominates the global market due to presence of majority key players and higher adoption of advanced BCI technologies for healthcare applications in the region. Asia Pacific is expected to witness fastest growth over the forecast period supported by growing disposable income, increasing health awareness, and improving healthcare infrastructure in the region. Key players analysis - Key players operating in the brain computer interface market are Neuralink Corporation, Neurable, Emotiv Inc., BitBrain, Alpha Omega, Blackrock Microsystems, LLC, Femtonics Ltd, NeuroNexus, Opto Circuits (India) Limited, BIOTRONIK, Plexon Inc., Noldus Information Technology, NextMind, Nectome, and Paradromics. The market remains highly consolidated with few major players accounting for over 70% of the market share. Read More, https://www.insightprobing.com/brain-computer-interface-market-trends-size-and-share-analysis/ The global bath bombs market is estimated to be valued at US$ 133.04 Billion in 2022 and is expected to exhibit a CAGR of 4% over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights.
Market Overview: Bath bombs are spherical or irregularly shaped products made of dry ingredients that dissolve in water to release aromatic essential oils. When added to a bath, they create a colorful, frothy mixture that nourishes the skin. The convenience of bath bombs and their ability to hydrate the skin make them a popular self-care product. Market key trends: One of the major trends gaining traction in the bath bombs market is the growing demand for natural and organic ingredients. Customers are increasingly preferring bath products made from natural essential oils, flower extracts, herbal ingredients and other natural additives over synthetic fragrances, colors and preservatives. This is prompting manufacturers to develop bath bombs containing aloe vera, coconut oil, avocado butter, shea butter, vitamins and other natural moisturizers that leave the skin feeling refreshed without potential side effects. Segment Analysis The global Bath Bombs Market Share is segmented on the basis of product type, distribution channel and region. By product type, the bath melts segment accounted for the largest market share in 2022 due to their easy to carry and use nature. Bath melts dissolve quickly in water providing relaxation and aromatic experience to users. Key Takeaways The global bath bombs market is expected to witness high growth, exhibiting a CAGR of 4% over the forecast period, due to increasing demand for premium bath and body care products and growing trend of self-care. Regional Analysis North America dominated the bath bombs market in 2022 and is expected to continue its dominance over the forecast period. This is attributed to high spending capacity of consumers and presence of key players in the region. Asia Pacific is expected to exhibit the fastest growth over the forecast period due to rising middle class population with high disposable income in countries such as China and India. Key Players Key players operating in the bath bombs market are Lush Ltd., Body Shop International Limited, The Village Company LLC, Pearl Bath Bombs, Hugo Naturals, Level Naturals, Swanky Sweet Pea, Heavenly Bubbles Ltd, The Natural Soap Company, and Oliver Rocket LLC. Lush Ltd. holds the largest market share due to wide product portfolio and widespread distribution network across the globe. Read More, https://www.insightprobing.com/bath-bombs-market-trends-size-and-share-analysis |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
February 2024
Categories
All
|